StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.16−0.05 (-1.56%)

Close on Nov 20, 2026Market cap $28.34MP/E –Yield –

ProMIS Neurosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for ProMIS Neurosciences

ProMIS Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ProMIS Neurosciences figures

See a number that looks wrong?